Regeneron Pharmaceuticals has received Japanese Ministry of Health,Labour and Welfare(MHLW)approval for its Eylea(aflibercept)injection to treat patients with neovascular age-related macular degeneration(wet AMD)symptoms. Regeneron chief ...
Tags: Regeneron Pharmaceuticals, Eylea Injection, wet AMD, George Yancopoulos
Neurotech, a developer of active implantable devices, has received CE mark approval for its ADNS-300 to treat refractory epilepsy. The surgically implanted ADNS-300 system operates as a pacemaker to produce stimulation towards the brain ...
Tags: active implantable devices, Neurotech, refractory epilepsy
A meta-analysis of Mederi Therapeutics' Stretta therapy demonstrated that the minimally invasive treatment using Stretta improves reflux symptoms and reduces esophageal acid exposure. Stretta Therapy, which involves delivery of ...
Tags: Stretta therapy, gastroesophageal reflux disease, medical management
Takeda Pharmaceuticals USA (TPUSA) and Affymax have announced supply agreement with US Renal Care for Omontys (peginesatide) injection in the US. Under the agreement, US Renal Care will purchase Omontys for use within its organization and ...
Tags: Medicine, Omontys Injection
Baxter International's Gammagard liquid 10% [Immune Globulin Infusion (Human)] has got approval from the US Food and Drug Administration (FDA) as a treatment for multifocal motor neuropathy (MMN). Baxter has been given Orphan Drug ...
Tags: Gammagard liquid, FDA, MMN patients